Interestingly, GPC1-enriched cirExos declined following PDAC resection, and a high cirExos GPC1 level was associated with a large tumor size, indicating that GPC1 might be associated with tumor burden and might not be a PDAC biomarker. This evidence concerns the gene GPC1 and neoplasm.